Browse Tag

dilution

Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation Stock Today: ACHR Slips Again as Dilution Fears Collide With Big-Money Buying (13 November 2025)

Updated: 13 November 2025, during U.S. trading hours Archer Aviation stock (NYSE: ACHR) is trading lower again on Thursday as Wall Street continues to digest last week’s blockbuster capital raise, the planned Hawthorne Airport acquisition in Los Angeles, and a fresh round of analyst target cuts — even as major institutional investors and Cathie Wood’s ARK Invest keep buying the dip.  Benzinga+1 ACHR stock today: price action and volatility By early afternoon on 13 November 2025, Archer Aviation shares were changing hands around $8.65, down from Wednesday’s close near $8.94, a drop of roughly 3% on the day.  Stocktwits Over the last year,
Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

Vor Biopharma (VOR) Prices $100M Stock Offering at $10; Shares Slide as Investors Weigh Dilution — Nov. 11, 2025

What happened today Vor Biopharma Inc. (NASDAQ: VOR) priced an underwritten public offering of 10 million common shares at $10.00 per share for $100 million in expected gross proceeds. The company granted underwriters a 30‑day option to purchase up to 1.5 million additional shares. Vor expects the transaction to close on or about Wednesday, Nov. 12, 2025, subject to customary conditions. J.P. Morgan, Jefferies, Citigroup, and TD Cowen are joint book‑running managers. The deal is being made under a shelf registration declared effective on March 31, 2025; a final prospectus supplement will be filed with the SEC. GlobeNewswire+1 How the
11 November 2025
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Stock Price & Recent Movement Picard Medical stock has been extremely volatile this month. After its Aug. 29 IPO at $4.00, PMI traded mostly under $10, but shot higher in mid-October. On Oct. 20 the stock closed around $11.60, then hit a new 52-week peak near $13.68 by Oct. 23 stockanalysis.com. However, on Oct. 24 trading opened sharply lower. By mid-day Oct. 24 the shares were about $3.30, erasing nearly all the prior week’s gains investing.com. Investing.com confirms that as of Oct. 24, 2025 PMI was trading at $3.27 with a previous close of $13.20 investing.com. This represents a collapse
Go toTop